EyePoint, Inc. (EYPT)

NASDAQ: EYPT · Real-Time Price · USD

15.75

-0.01 (-0.06%)

At close: Mar 6, 2026, 4:00 PM EST

15.76

+0.01 (0.06%)

After-hours: Mar 6, 2026, 5:59 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Developing and Commercializing Innovative Ophthalmic Products			46.02M	41.40M	36.94M	34.44M	20.37M
Developing and Commercializing Innovative Ophthalmic Products Growth			11.14%	12.09%	7.27%	69.10%	345.53%
Total			46.02M	41.40M	36.94M	34.44M	20.37M
Total Growth			11.14%	12.09%	7.27%	69.10%	345.53%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
United States (U.S.)			45.27M	40.48M	35.99M	22.62M	19.14M
United States (U.S.) Growth			11.83%	12.48%	59.07%	18.18%	-
China			648.00K	823.00K	851.00K	11.71M	1.12M
China Growth			-21.26%	-3.29%	-92.73%	944.87%	-
United Kingdom (U.K.)			100.00K	100.00K	100.00K	100.00K	100.00K
United Kingdom (U.K.) Growth			0%	0%	0%	0%	-
Total			46.02M	41.40M	36.94M	34.44M	20.37M
Total Growth			11.14%	12.09%	7.27%	69.10%	-

Source: S&P Global Market Intelligence.